Cited by 879Cancer-related Molecular PathwaysCervical Cancer and HPV ResearchUbiquitin and proteasome pathways

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Open access

Huibregtse, J.M., Scheffner, M., Howley, P.M.·1991·The EMBO Journal

DOI 10.1002/j.1460-2075.1991.tb04990.xPMC PMC453163

Open this paper in CoChat — free account

Abstract

The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1991.tb04990.x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citation
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Self-citation
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Self-citation
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403

Show all 46 references

Sorted by citations

Items 301–400 of 879

Small tumor antigen of polyomaviruses: Role in viral life cycle and cell transformation
Khalili, K., Sariyer, I. K., & Safak, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21326 · Cited by 63
Biology of Human Papillomavirus–Related Oropharyngeal Cancer
Howard, J. D., & Chung, C. H. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2012.03.002 · Cited by 62
A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding α-Helix Partners Displays Reduced Oncogenic Potential In Vivo
Nguyen, M. L., Song, S., Liem, A., Androphy, E. J., Liu, Y., & Lambert, P. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13039-13048.2002 · Cited by 62
Recognition and Ubiquitination of Salmonella Type III Effector SopA by a Ubiquitin E3 Ligase, HsRMA1
Zhang, Y., Higashide, W., Dai, S., Sherman, D. M., & Zhou, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506309200 · Cited by 62
Roles for hypoxia-regulated genes during cervical carcinogenesis: Somatic evolution during the hypoxia–glycolysis–acidosis sequence
Lee, W., Huang, S.-C., Hsu, K., Tzeng, C., & Shen, W.-L. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.034 · Cited by 61
A new cell culture model to genetically dissect the complete human papillomavirus life cycle
Bienkowska‐Haba, M., Łuszczek, W., Myers, J. E., Keiffer, T. R., DiGiuseppe, S., Polk, P., Bodily, J. M., Scott, R. S., & Sapp, M. J. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006846 · Cited by 61
Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis
Li, R., Li, X., Gong, T., Liu, J., Li, Y., Zhou, X., Li, Y., & Zheng, X. M. (2022) · Molecular Oral Microbiology · doi:10.1111/omi.12403 · Cited by 66
The ubiquitin ligase E6‐AP promotes degradation of α‐synuclein
Mulherkar, S. A., Sharma, J., & Jana, N. R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06293.x · Cited by 60
Manipulation of the innate immune response by human papillomaviruses
Hong, S., & Laimins, L. A. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.004 · Cited by 60
PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein
Gao, Q., Kumar, A., Srinivasan, S. V., Singh, L., Mukai, H., Ono, Y., Wazer, D. E., & Band, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14824 · Cited by 60
Human papillomaviruses target the double-stranded RNA protein kinase pathway
Hebner, C. M., Wilson, R., Rader, J. S., Bidder, M., & Laimins, L. A. (2006) · Journal of General Virology · doi:10.1099/vir.0.82098-0 · Cited by 60
Coupling of Human DNA Excision Repair and the DNA Damage Checkpoint in a Defined in Vitro System
Lindsey-Boltz, L. A., Kemp, M. G., Reardon, J. T., DeRocco, V., Iyer, R. R., Modrich, P., & Sancar, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542787 · Cited by 59
Structure of the p53 degradation complex from HPV16
Wang, J. C. K., Baddock, H. T., Mafi, A., Foe, I. T., Bratkowski, M. A., Lin, T., Jensvold, Z. D., López, M. P., Stokoe, D., Eaton, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45920-w · Cited by 59
Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy
Yuan, C.-H., Filippova, M., & Duerksen-Hughes, P. J. (2012) · Viruses · doi:10.3390/v4123831 · Cited by 68
The PY-motif of Bul1 protein is essential for growth of Saccharomyces cerevisiae under various stress conditions
Yashiroda, H., Kaida, D., Toh‐e, A., & Kikuchi, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00535-6 · Cited by 59
Interactions Between Papillomavirus Proteins and Tumor Suppressor Gene Products
Vousden, K. H. (1994) · Advances in cancer research · doi:10.1016/s0065-230x(08)60833-7 · Cited by 59
Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas
Göttgens, E., Bussink, J., Leszczyńska, K. B., Peters, H., Span, P. N., & Hammond, E. M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.06.2531 · Cited by 55
Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination
Mortensen, F., Schneider, D., Barbic, T., Sladewska-Marquardt, A., Kühnle, S., Marx, A., & Scheffner, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505923112 · Cited by 57
Self-citation
Proteomic Analysis and Identification of Cellular Interactors of the Giant Ubiquitin Ligase HERC2
Galligan, J. T., Martínez-Noël, G., Arndt, V., Hayes, S., Chittenden, T. W., Harper, J. W., & Howley, P. M. (2014) · Journal of Proteome Research · doi:10.1021/pr501005v · Cited by 62
Self-citation
Human papillomavirus oncoproteins and apoptosis (Review)
Jiang, P., & Yue, Y. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1374 · Cited by 58
p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers
Shai, A., Pitot, H. C., & Lambert, P. F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5266 · Cited by 59
E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1
Drews, C. M., Case, S., & Pol, S. V. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007575 · Cited by 58
E6-Associated Protein Is Required for Human Papillomavirus Type 16 E6 to Cause Cervical Cancer in Mice
Shai, A., Pitot, H. C., & Lambert, P. F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3307 · Cited by 58
Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome
Pastuzyn, E. D., & Shepherd, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00234 · Cited by 57
Gps2, a Protein Partner for Human Papillomavirus E6 Proteins
Degenhardt, Y., & Silverstein, S. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.151-160.2001 · Cited by 57
Human papillomaviruses and oral neoplasia
Yeudall, W. A. (1992) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/0964-1955(92)90015-s · Cited by 57
Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin
Kiyono, T., Hiraiwa, A., Ishii, S., Takahashi, T., & Ishibashi, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4656-4661.1994 · Cited by 55
CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells
Inturi, R., & Jemth, P. (2021) · Virology · doi:10.1016/j.virol.2021.07.005 · Cited by 55
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
The Human Papillomavirus (HPV) E6* Proteins from High-Risk, Mucosal HPVs Can Direct Degradation of Cellular Proteins in the Absence of Full-Length E6 Protein
Pim, D., Tomaić, V., & Banks, L. (2009) · Journal of Virology · doi:10.1128/jvi.00539-09 · Cited by 56
Cervical Cancers Require the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncoprotein Even in the Presence of the Viral E6 Oncoprotein
Jabbar, S. F., Park, S., Schweizer, J., Berard‐Bergery, M., Pitot, H. C., Lee, D., & Lambert, P. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3085 · Cited by 57
Telomerase Induction in HPV Infection and Oncogenesis
Katzenellenbogen, R. A. (2017) · Viruses · doi:10.3390/v9070180 · Cited by 61
How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery
Bordignon, V., Domenico, E. G. D., Trento, E., D’Agosto, G., Cavallo, I., Pontone, M., Pimpinelli, F., Mariani, L., & Ensoli, F. (2017) · Viruses · doi:10.3390/v9120390 · Cited by 60
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Grm, H. Š., & Banks, L. (2004) · Journal of General Virology · doi:10.1099/vir.0.80035-0 · Cited by 56
Genomic Organization of theUBE3A/E6-AP Gene and Related Pseudogenes
Kishino, T., & Wagstaff, J. E. (1998) · Genomics · doi:10.1006/geno.1997.5093 · Cited by 56
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines
Mantovani, F., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202688 · Cited by 56
Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance
Nicolaides, L., Davy, C. E., Raj, K., Kranjec, C., Banks, L., & Doorbar, J. (2011) · Virology · doi:10.1016/j.virol.2011.03.017 · Cited by 58
The role of IRES trans-acting factors in carcinogenesis
Faye, M. D., & Holčík, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.012 · Cited by 61
Ubiquitination and TRAF signaling
Pineda, G., Ea, C.-K., & Chen, Z. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_7 · Cited by 56
Modulating Radiation Resistance by Inhibiting Ribonucleotide Reductase in Cancers with Virally or Mutationally Silenced p53 Protein
Kunos, C. A., Chiu, S., Pink, J. J., & Kinsella, T. J. (2009) · Radiation Research · doi:10.1667/rr1858.1 · Cited by 54
Long-Term Effect of Interferon on Keratinocytes That Maintain Human Papillomavirus Type 31
Chang, Y. E., Pena, L., Sen, G. C., Park, J. K., & Laimins, L. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8864-8874.2002 · Cited by 54
Interaction of oncogenic papillomavirus E6 proteins with fibulin-1
Du, M., Fan, X., Hong, E., & Chen, J. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02041-7 · Cited by 54
Analysis of a Protein-Binding Domain of p53
Ruppert, J. M., & Stillman, B. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3811 · Cited by 54
Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein
Grm, H. Š., Massimi, P., Gammoh, N., & Banks, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208701 · Cited by 53
p63 Is Necessary for the Activation of Human Papillomavirus Late Viral Functions upon Epithelial Differentiation
Mighty, K. K., & Laimins, L. A. (2011) · Journal of Virology · doi:10.1128/jvi.00750-11 · Cited by 52
Peptide Interactions Stabilize and Restructure Human Papillomavirus Type 16 E6 To Interact with p53
Ansari, T., Brimer, N., & Pol, S. V. (2012) · Journal of Virology · doi:10.1128/jvi.01236-12 · Cited by 51
Molecular imaging of protein-protein interactions: controlled expression of p53 and large T-antigen fusion proteins in vivo.
Luker, G. D., Sharma, V., Pica, C. M., Prior, J. L., Li, W., & Piwnica-Worms, D. R. (2003) · PubMed · Cited by 52
Dual degradation mechanisms ensure disposal of NHE6 mutant protein associated with neurological disease
Roxrud, I., Raiborg, C., Gilfillan, G. D., Strømme, P., & Stenmark, H. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.012 · Cited by 54
The Structural and Dynamic Response of MAGI-1 PDZ1 with Noncanonical Domain Boundaries to the Binding of Human Papillomavirus E6
Charbonnier, S., Nominé, Y., Ramírez, J., Luck, K., Chappelle, A., Stote, R. H., Travé, G., Kieffer, B., & Atkinson, R. A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.015 · Cited by 49
Human Papilloma Virus (HPV) and Host Cellular Interactions
Mammas, I., Sourvinos, G., Giannoudis, A., & Spandidos, D. A. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9056-6 · Cited by 51
Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens
Liu, W., Jiang, X.-Y., & Zhang, Z. (2010) · Archives of Virology · doi:10.1007/s00705-010-0635-y · Cited by 51
Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes
Martínez-Noël, G., Luck, K., Kühnle, S., Desbuleux, A., Szajner, P., Galligan, J. T., Rodriguez, D., Zheng, L., Boyland, K. A., Leclere, F., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.021 · Cited by 53
Self-citation
The Ubiquitin-interacting Motif Protein, S5a, Is Ubiquitinated by All Types of Ubiquitin Ligases by a Mechanism Different from Typical Substrate Recognition
Uchiki, T., Kim, H. T., Zhai, B., Gygi, S. P., Johnston, J. A., O’Bryan, J. P., & Goldberg, A. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900556200 · Cited by 48
The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein
Hampson, L., Li, C., Oliver, A. W., Kitchener, H. C., & HAMPSON, I. N. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.5.1249 · Cited by 49
Nuclear Entry of High-Risk Human Papillomavirus Type 16 E6 Oncoprotein Occurs via Several Pathways
Roux, L. L., & Moroianu, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2330-2337.2003 · Cited by 49
β-HPV 5 and 8 E6 Disrupt Homology Dependent Double Strand Break Repair by Attenuating BRCA1 and BRCA2 Expression and Foci Formation
Wallace, N. A., Robinson, K. L., Howie, H. L., & Galloway, D. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004687 · Cited by 53
Genomic Instability and Telomerase Activity in Human Bronchial Epithelial Cells during Immortalization by Human Papillomavirus-16 E6 and E7 Genes
Coursen, J. D., Bennett, W. P., Gollahon, L., Shay, J. W., & Harris, C. C. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3670 · Cited by 48
Untitled work
(2000) · PubMed · Cited by 48
Molecular Targets for Human Papillomaviruses: Prospects for Antiviral Therapy
Phelps, W. R., Barnes, J., & Lobe, D. C. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900501 · Cited by 48
Ovarian cancer screening. The role of ultrasound in early detection
Karlan, B. Y., & PLATT, L. D. (1995) · Cancer · doi:10.1002/1097-0142(19951115)76:10+ · Cited by 39
Induction of 18A2/mts1 Gene Expression and Its Effects on Metastasis and Cell Cycle Control
Parker, C., WHITTAKER, P. A., Usmani, B. A., Lakshmi, M. S., & Sherbet, G. V. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.1021 · Cited by 48
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
Shah, M., Anwar, M. A., Park, S.-H., Jafri, S. S., & Choi, S. (2015) · Scientific Reports · doi:10.1038/srep13446 · Cited by 47
Papillomavirus interaction with cellular chromatin
You, J. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.09.009 · Cited by 47
Genetic variations in human papillomavirus and cervical cancer outcomes
Rader, J. S., Tsaih, S., Fullin, D., Murray, M. W., Iden, M., Zimmermann, M. T., & Flister, M. J. (2018) · International Journal of Cancer · doi:10.1002/ijc.32038 · Cited by 48
The ‘wildtype’ conformation of p53: epitope mapping using hybrid proteins
Wang, P. L., Sait, F., & Winter, G. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204316 · Cited by 47
Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16
Magal, S. S., Jackman, A., Ish-Shalom, S., Edry‐Botzer, L., Gonen, P., Schlegel, R., & Sherman, L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80453-0 · Cited by 47
UPL1 and 2, two 405 kDa ubiquitin–protein ligases from Arabidopsis thaliana related to the HECT‐domain protein family
Bates, P. W., & Vierstra, R. D. (1999) · The Plant Journal · doi:10.1046/j.1365-313x.1999.00590.x · Cited by 47
Inhibition of E6-induced Degradation of its Cellular Substrates by Novel Blocking Peptides
Grm, H. Š., Weber, M., Elston, R., McIntosh, P. B., Griffin, H. M., Banks, L., & Doorbar, J. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.079 · Cited by 46
Cervical Epithelial Cells Transduced with the Papillomavirus E6/E7 Oncogenes Maintain Stable Levels of Oncoprotein Expression but Exhibit Progressive, Major Increases in hTERT Gene Expression and Telomerase Activity
Baege, A. C., Berger, A., Schlegel, R., Veldman, T., & Schlegel, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62552-7 · Cited by 46
The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27Kip1
Pedroza-Saavedra, A., Lam, E. W. ‐., Esquivel-Guadarrama, F. R., & Gutiérrez‐Xicoténcatl, L. (2010) · Virology · doi:10.1016/j.virol.2010.01.009 · Cited by 45
Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation
Zhang, Y., Dakic, A., Chen, R., Dai, Y., Schlegel, R., & Liu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22036 · Cited by 48
The APOBEC3 genes and their role in cancer: insights from human papillomavirus
Smith, N. J., & Fenton, T. R. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0011 · Cited by 47
Differential display and gene arrays to examine auditory plasticity
Lomax, M. I., Huang, L., Cho, Y., Gong, T.-W. L., & Altschuler, R. A. (2000) · Hearing Research · doi:10.1016/s0378-5955(00)00139-8 · Cited by 45
Metastasis-Associated mts1 Gene Expression Correlates with Increased p53 Detection in the B16 Murine Melanoma
Parker, C., Lakshmi, M. S., Piura, B., & Sherbet, G. V. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.343 · Cited by 45
Diverse mechanisms evolved by DNA viruses to inhibit early host defenses
Crow, M. S., Lum, K. K., Sheng, X., Song, B., & Cristea, I. M. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1226250 · Cited by 46
Angelman syndrome–associated point mutations in the Zn2+-binding N-terminal (AZUL) domain of UBE3A ubiquitin ligase inhibit binding to the proteasome
Kühnle, S., Martínez-Noël, G., Leclere, F. E., Hayes, S., Harper, J. W., & Howley, P. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004653 · Cited by 45
Self-citation
Epstein-Barr virus: Current questions and challenges
Frappier, L. (2021) · Tumour Virus Research · doi:10.1016/j.tvr.2021.200218 · Cited by 44
Down-Regulation of GRIM-19 Expression Is Associated With Hyperactivation of STAT3-Induced Gene Expression and Tumor Growth in Human Cervical Cancers
Zhou, Y. Y., Li, M., Wei, Y., Feng, D., Peng, C., Weng, H., Ma, Y., Bao, L., Nallar, S. C., Kalakonda, S., et al. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0003 · Cited by 44
Stabilization and Activation of p53 by the Coactivator Protein TAFII31
Buschmann, T., Lin, Y., Aithmitti, N., Fuchs, S. Y., Lu, H., Resnick‐Silverman, L., Manfredi, J. J., Ronai, Z. A., & Wu, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007955200 · Cited by 43
Multiple Genetic Changes Are Required for Efficient Immortalization of Different Subtypes of Normal Human Mammary Epithelial Cells
Ratsch, S. B., Gao, Q., Srinivasan, S. V., Wazer, D. E., & Band, V. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0143:mgcarf]2.0.co;2 · Cited by 44
p53-based therapeutics for head and neck squamous cell carcinoma
Tassone, P. T., Old, M. O., Teknos, T. N., & Pan, Q. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.03.447 · Cited by 43
Papillomaviruses and Endocytic Trafficking
Siddiqa, A., Broniarczyk, J. K., & Banks, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092619 · Cited by 43
Purification and Biophysical Characterization of a Minimal Functional Domain and of an N-Terminal Zn2+-Binding Fragment from the Human Papillomavirus Type 16 E6 Protein
Lipari, F., McGibbon, G. A., Wardrop, E., & Cordingley, M. G. (2001) · Biochemistry · doi:10.1021/bi001837+ · Cited by 43
Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line
Zhong, L., Pan, H., Zhou, X., Ye, D., Zhang, L., Yang, X. Y., Chen, W., & Zhang, Z. (2008) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2007.12.002 · Cited by 43
Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: Implications for p53 ubiquitination
Reyes‐Hernández, O. D., Mejía‐García, A., Sánchez‐Ocampo, E. M., Cabañas-Cortés, M. A., Ramírez‐Noguera, P., Chávez-González, L., Gonzalez, F. J., & Elizondo, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.007 · Cited by 43
Interaction between HERC1 and M2‐type pyruvate kinase
García-Gonzalo, F. R., Cruz, C., Muñoz, P., Mazurek, S., EIGENBRODT, E., Ventura, F., Bartrons, R., & Rosa, J. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00205-9 · Cited by 42
Prediction of Human Papillomavirus 16 E6 Gene Expression and Cervical Intraepithelial Neoplasia Progression by Methylation Status
Hublarová, P., Hrstka, R., Rotterová, P., Rotter, L., Coupkova, M., Badal, V., Nenutil, R., & Vojtěšek, B. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e31819d8a5c · Cited by 43
Advances in surface plasmon resonance biomolecular interaction analysis mass spectrometry (BIA/MS)
Nelson, R. W., & Krone, J. R. (1999) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199903/04)12:2 · Cited by 71
Growth Inhibition of Cervical Tumor Cells by Antisense Oligodeoxynucleotides Directed to the Human Papillomavirus Type 16 E6 Gene
Álvarez-Salas, L. M., Arpawong, T. E., & DiPaolo, J. A. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.441 · Cited by 42
MicroRNA Analysis in Human Papillomavirus (HPV)-Associated Cervical Neoplasia and Cancer
McBee, W. C., Gardiner, A. S., Edwards, R. P., Lesnock, J. L., & Bhargava, R. (2011) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000114 · Cited by 39
Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation
Altamura, G., Power, K., Martano, M., Uberti, B. Ď., Galiero, G., Luca, G. D., Maiolino, P., & Borzacchiello, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-35723-7 · Cited by 41
Cellular Steady-State Levels of “High Risk” but Not “Low Risk” Human Papillomavirus (HPV) E6 Proteins Are Increased by Inhibition of Proteasome-Dependent Degradation Independent of Their p53- and E6AP-Binding Capabilities
Kehmeier, E. S., Rühl, H., Voland, B., Stoppler, M. C., Androphy, E. J., & Stöppler, H. (2002) · Virology · doi:10.1006/viro.2002.1502 · Cited by 41
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
Analysis of JNK, Mdm2 and p14ARF contribution to the regulation of mutant p53 stability
Buschmann, T., Minamoto, T., Wagle, N., Fuchs, S. Y., Adler, V., Mai, M., & Ronai, Z. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3387 · Cited by 41
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
Copping, N. A., McTighe, S. M., Fink, K. D., & Silverman, J. L. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01082-x · Cited by 42
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6
Camus, S., Higgins, M., Lane, D. P., & Laı́n, S. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00054-1 · Cited by 39
Pitx2a Binds to Human Papillomavirus Type 18 E6 Protein and Inhibits E6-mediated P53 Degradation in HeLa Cells
Wei, Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502974200 · Cited by 40
The interaction between p53 and papillomaviruses
Mantovani, F., & Banks, L. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0142 · Cited by 40
BMK1 is involved in the regulation of p53 through disrupting the PML–MDM2 interaction
Yang, Q., Liao, L., Deng, X., Chen, R., Gray, N. S., Yates, J. R., & Lee, J. D. (2012) · Oncogene · doi:10.1038/onc.2012.332 · Cited by 39
KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress
Soto, D. R., Barton, C. E., Münger, K., & McLaughlin-Drubin, M. E. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006661 · Cited by 41

Authors: Huibregtse, J. M., Scheffner, M., & Howley, P. M.
Affiliations: National Institutes of Health (US)
ORCID: Huibregtse, J.M.
Scheffner, M.
Howley, P.M.
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1991-12-01
Volume: 10
Issue: 13
Pages: 4129-4135
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1002/j.1460-2075.1991.tb04990.x
PMC: PMC453163
OpenAlex: W140061535
Cited by: 879
References: 46
Citations by year: 2026: 8 · 2025: 15 · 2024: 16 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 27 · 2019: 18 · 2018: 28 · 2017: 29 · 2016: 19 · 2015: 26 · 2014: 29 · 2013: 28 · 2012: 41
FWCI: 5.96
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
National Cancer Institute
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: p53, E6 oncoprotein, HPV16, HPV 18, UBE3A, ubiquitin-mediated proteolysis, p53 degradation, protein-protein interaction, keratinocytes, tumor suppressor
MeSH terms: Animals, Cell Line, Chromatography, Gel, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Humans, Hydrolysis, Oncogene Proteins, Viral, Plasmids, Protein Binding, Proteins, Repressor Proteins, Reticulocytes, Tumor Suppressor Protein p53, Papillomaviridae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks